Bipolar_disorder - Articles - Page 4

The Bipolar Spectrum: Practical Tips for Diagnosis and Treatment

January 1, 2018

Chris Aiken, MD Director of the Mood Treatment Center and instructor at the Wake Forest University School of Medicine. Co-author, with Jim Phelps, of Bipolar, Not So Much (W. W. Norton & Company). Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article, Dr. Aiken draws on his vast clinical experience to help us recognize the different types of patients who might present some degree of bipolarity, then provides tips on evidence-based treatments.

Understanding the Bipolar Spectrum: Tips on Diagnosis

January 1, 2018

Chris Aiken, MD

Chris Aiken, MD

Director of the Mood Treatment Center and instructor at the Wake Forest University School of Medicine. Co-author, with Jim Phelps, of Bipolar, Not So Much (W. W. Norton & Company). Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Aiken discusses the history of bipolar disorder and goes through some key tips on diagnosing bipolar disorder, including the bipolarity index and specific questions to ask patients to help narrow down the diagnosis.

Disruptive Mood Dysregulation Disorder: A Primer

July 1, 2016

Ellen Leibenluft, MD

Chronically irritable children are not at increased risk to develop manic episodes as they age; instead, they are at increased risk for anxiety and unipolar depression later in life. Moreover, unlike children with bipolar disorder (BD), chronically irritable children do not tend to have unusually strong family histories of BD. Rather, there are both genetic and familial links between chronic irritability and unipolar depression.

Treating Disruptive Behavior Disorders in Children

July 1, 2016

Peter Parry, MBBS

Child & adolescent psychiatrist; medical director, child & youth mental health services at Lady Cilento Children’s Hospital, Brisbane, Australia; senior lecturer, University of Queensland, visiting senior lecturer, Flinders University Dr. Parry has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Disruptive behavioral disorders are the most common preadolescent disorders in child psychiatry and behavioral pediatrics. Dr. Parry discusses the landscape, diagnosis, and treatment of disruptive mood dysregulation disorder (DMDD).

Evolution of Childhood Bipolar Disorder in the United States

July 1, 2016

Many clinicians are still unclear about how bipolar disorder got to be such a common diagnosis, most specifically in the United States. Dr. Carlson describes a historical perspective on bipolar disorder as a diagnosis in children.

Antipsychotic Polypharmacy: Helpful or Harmful?

January 1, 2016

Kelly N. Gable, Pharm.D and Daniel Carlat, MD

Kelly N. Gable, Pharm.D Associate Professor, SIUE School of Pharmacy Psychiatric Care Provider, Places for People Dr. Gable has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. Daniel Carlat, MD Editor-in-Chief, Publisher, The Carlat Report. Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Prescribing two antipsychotics to a single patient is a common practice in clinical settings. Increasingly, we are being scolded for this practice. If possible, stick with a single antipsychotic. But if the situation seems to call for polypharmacy, here are some factors to guide your decision-making.

Managing Bipolar Disorder: Practical Tips

January 1, 2016

Stephen M. Strakowski, MD

Stephen M. Strakowski, MD Senior Vice President and Chief Strategy Officer of UC Health; Professor of Psychiatry & Behavioral Neuroscience, Psychology & BME at the University of Cincinnati Dr. Strakowski discloses that he has been a paid consultant to Sunovion and Procter & Gamble. Dr. Carlat has reviewed this article and has found no evidence of bias in this educational activity.

Dr. Strakowski shares tips on diagnosing bipolar disorder, in addition to insight on treatment strategies such as maintaining a regular schedule, mood charting, cognitive behavioral therapy, and medication.

Saphris Approved for Pediatric Bipolar Disorder—What Do the Data Show?

April 1, 2015

In March 2015, the US Food and Drug Administration (FDA) approved Actavis’ asenapine (Saphris) for the acute treatment of manic or mixed episodes associated with bipolar disorder in kids between 10 and 17 years.

Symbyax Helps Kids with Bipolar Depression—But Has Downsides

January 1, 2015

A new study on the safety and efficacy of Symbyax (olanzapine/fluoxetine combination or OFC) in kids with bipolar I depression is in press and will be published soon.